This page is historical material reflecting the Feedback Loop Blog as it existed on May 8, 2013. This page is no longer updated and links to external websites and some internal pages may not work.
May 8, 2013

Archived: Budget Outlook for Fiscal Year 2013 and Beyond

As a result of the sequestration, the NIGMS full-year appropriation for Fiscal Year 2013 was reduced by about 5% compared to Fiscal Year 2012. This reduction brings our operating budget to $2,291,294,437. Our financial management plan outlines the Institute’s fiscal policies, which are consistent with NIH’s policies: Research Project Grants (RPGs)
  • Inflationary increases will be discontinued for all competing and noncompeting awards (both modular and nonmodular).
  • All noncompeting grants will be reduced by 3.5% from the Fiscal Year 2013 committed level. Commitments in Fiscal Year 2014 and beyond will remain unchanged.
  • Overall average costs for competing RPGs will be at approximately the Fiscal Year 2012 level. Inflationary increases for future-year commitments will be discontinued.
  • Fiscal Year 2013 noncompeting awards that have already been issued at a reduced level will be revised upward to reflect the 3.5% reduction.
  • New investigators on R01-equivalent awards will be supported at a success rate equivalent to that of established investigators submitting new (Type 1) R01-equivalent applications.
  • We anticipate funding 758 competing RPGs, with a success rate of 18% (see comparisons for previous years).
Ruth L. Kirschstein National Research Service Awards
  • The stipend levels established in Fiscal Year 2012 will be continued this fiscal year.
Centers and Other Mechanisms
  • Noncompeting awards will be reduced by 3.5% from the initial Fiscal Year 2013 committed level.

About the Author

Judith Greenberg

Judith Greenberg

Before her retirement in October 2020, Judith was the deputy director of NIGMS and the acting director of the Division of Biophysics, Biomedical Technology, and Computational Biosciences. In the past, she also served as the acting director of the Institute and as the director of the former Division of Genetics and Developmental Biology. She led the development of the NIGMS strategic plan issued in 2008 and the development and implementation of the NIGMS strategic plan for training issued in 2011.